Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

od Taniyama, T.K., Hashimoto, K., Katsumata, N., Hirakawa, A., Yonemori, K., Yunokawa, M., Shimizu, C., Tamura, K., Ando, M., Fujiwara, Y.
Wydane 2014

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site

od Yonemori, K, Ando, M, Yunokawa, M, Hirata, T, Kouno, T, Shimizu, C, Tamura, K, Katsumata, N, Hirakawa, A, Matsumoto, K, Yamanaka, Y, Arioka, H, Fujiwara, Y
Wydane 2009

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies

od Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K
Wydane w Br J Cancer (2016)